Medicare Enrolled
Dr. Nehal Mehta, MD
Pulmonary Disease · Bridgewater, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehta
Dr. Nehal Mehta is a pulmonary disease specialist in Bridgewater, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 4,243 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Mehta received a total of $14,948 from 50 pharmaceutical and/or device companies across 1037 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in NJ
$14,948 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,243
Medicare services
Top 6% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$51
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
931 | $104 | $693 |
| Therapeutic respiratory procedure, 15 minutes A one-on-one, face-to-face therapeutic procedure designed to improve respiratory function. The session includes monitoring and is billed per 15 minutes. |
854 | $9 | $78 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
700 | $23 | $252 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
306 | $42 | $145 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
285 | $45 | $145 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
168 | $58 | $472 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
105 | $29 | $406 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing patterns, and sleep duration. This test records physiological data while you sleep to assess your sleep quality and breathing function. |
103 | $132 | $1,270 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
102 | $34 | $430 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
102 | $39 | $292 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
102 | $51 | $374 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
102 | $0 | $2 |
| Lung volume measurement test A test that measures the largest amount of air you can breathe in and out. It evaluates the total capacity of your lungs. |
101 | $13 | $176 |
| New patient office visit, complex (60-74 min) | 101 | $179 | $1,320 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
93 | $50 | $143 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $135 | $930 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
44 | $34 | $79 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$14,948
Total received (2018-2024)
Avg $2,135/year across 7 years
Top 7% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,037
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,680
2023
$2,420
2022
$2,649
2021
$1,703
2020
$1,697
2019
$2,048
2018
$1,752
Payments by company (2024)
GlaxoSmithKline, LLC.
$329
Philips North America LLC
$303
AstraZeneca Pharmaceuticals LP
$282
Inspire Medical Systems, Inc.
$190
Genentech USA, Inc.
$158
Mylan Specialty L.P.
$157
Avadel CNS Pharmaceuticals, LLC
$152
GENZYME CORPORATION
$133
Actelion Pharmaceuticals US, Inc.
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$97
PFIZER INC.
$85
HARMONY BIOSCIENCES LLC
$84
Amgen Inc.
$70
Axsome Therapeutics, Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$67
Grifols USA, LLC
$66
Regeneron Healthcare Solutions, Inc.
$60
Harmony Biosciences Llc
$58
Electromed, Inc.
$53
United Therapeutics Corporation
$34
Novartis Pharmaceuticals Corporation
$28
Itamar Medical Inc
$23
Gilead Sciences, Inc.
$21
Pulmonx Corporation
$21
Circassia Inc.
$18
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 34.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,103
AstraZeneca Pharmaceuticals LP
$1,856
Philips Electronics North America Corporation
$1,110
Boehringer Ingelheim Pharmaceuticals, Inc.
$938
Mylan Specialty L.P.
$849
GENZYME CORPORATION
$643
Genentech USA, Inc.
$535
Inspire Medical Systems, Inc.
$492
Regeneron Healthcare Solutions, Inc.
$430
Grifols USA, LLC
$405
Sunovion Pharmaceuticals Inc.
$370
Novartis Pharmaceuticals Corporation
$336
Philips North America LLC
$303
Actelion Pharmaceuticals US, Inc.
$293
Amgen Inc.
$277
E.R. Squibb & Sons, L.L.C.
$275
JAZZ PHARMACEUTICALS INC.
$275
Pulmonx Corporation
$269
HARMONY BIOSCIENCES LLC
$268
Takeda Pharmaceuticals U.S.A., Inc.
$266
Electromed, Inc.
$257
Teva Pharmaceuticals USA, Inc.
$203
Inari Medical, Inc.
$201
Jazz Pharmaceuticals Inc.
$199
Axsome Therapeutics, Inc.
$186
Avadel CNS Pharmaceuticals, LLC
$185
Insmed, Inc.
$165
PFIZER INC.
$138
Advanced Respiratory, Inc
$109
United Therapeutics Corporation
$108
Shire North American Group Inc
$96
Harmony Biosciences LLC
$91
Mallinckrodt Hospital Products Inc.
$88
Baxter Healthcare
$75
SANOFI-AVENTIS U.S. LLC
$73
Resmed Corp
$71
Merck Sharp & Dohme Corporation
$59
Harmony Biosciences Llc
$58
Janssen Pharmaceuticals, Inc
$53
Circassia Pharmaceuticals Inc
$41
Gilead Sciences, Inc.
$35
Merck Sharp & Dohme LLC
$29
Mallinckrodt LLC
$28
Itamar Medical Inc
$23
Circassia Inc.
$18
Phadia US Inc.
$15
Allergan Inc.
$14
Inogen, Inc.
$13
Horizon Pharma plc
$13
Mallinckrodt Enterprises LLC
$12
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIR 11 · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · AVYCAZ · AirDuo Digihaler · AirSense · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CAMZYOS · CHARTIS CATHETER · CINQAIR · COMBIVENT RESPIMAT · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · ELIQUIS · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · Inspire Upper Airway Stimulation System · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NIOX · NUCALA · OFEV · OPSUMIT MACITENTAN · PREVNAR 20 · Prolastin-C · Prolastin-C Liquid · QVAR · RAYOS · Respiratoriy Care Undiv · S · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · WAKIX · Wakix · WatchPATONE · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
135
County median income
$135,960
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL - SOMERSET
3.5 mi
3.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mehta is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mehta experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mehta performed 931 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $14,948 from 50 companies across 1,037 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other pulmonary diseases in Bridgewater?
Dr. Mehta's average Medicare payment per service is $51. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Bridgewater
Browse pulmonary diseases in Bridgewater ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Philips Electronics North America Corporation Payments to Doctors
See all physicians who received payments from Philips Electronics North America Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology